Cairo University
Cairo, 12613, Egypt
NCT Number: NCT07012252
The research aimed to improve surgical techniques and long-term outcomes by utilizing this advanced imaging technology to illuminate the structural abnormalities of the anterior segment in eyes with primary congenital glaucoma.
Looking for future studies?
Notify Me1 week–72 week
All sexes
Interventional
Not applicable
Cairo, 12613, Egypt
Primary congenital glaucoma (PCG) is a rare disease, but it is responsible for 2.5%-15% of all documented cases of pediatric blindness.
The main target of the treatment of pediatric glaucoma is to control the IOP surgically. However, medical treatment could be instituted as a temporary and/or adjunctive option to maximize Intraocular pressure (IOP) control. Initial goniotomy or trabeculotomy have been detected to have high success rates. Trabeculotomy has a comparable long-term success rate in most patients of PCG. The success rate of trabeculotomy is lower in advanced or late-presenting patients.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Infants underwent optical coherence tomography.
Time frame: 6 months post-procedure
Central corneal thickness was measured using handheld anterior segment optical coherence tomography (HH AS-OCT).
Time frame: 6 months post-procedure
Trabecular-iris angle was measured using handheld anterior segment optical coherence tomography (HH AS-OCT).
Time frame: 6 months post-procedure
Iris thickness was measured using handheld anterior segment optical coherence tomography (HH AS-OCT).
Cairo University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04794634
Alzheimer Disease, Basal Ganglia Diseases
Amiens, France
View Trial DetailsNCT04698902
Arterial Occlusive Diseases, Arteriosclerosis
Madrid, Spain
View Trial DetailsNCT05517889
Artificial Intelligence, Optical Coherence Tomography
Maastricht, Limburg, Netherlands
View Trial DetailsNCT05223205
Eye Diseases, Macular Holes
Graz, Styria, Austria
View Trial Details